Provectus Biopharmaceuticals, Inc. Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| PROVECTUS BIOPHARMACEUTICALS, Inc. (AMEX: PVCT) | Delayed: 0.05 +0.01 (25.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $0.54 | |||
| Open | $0.05 | 52 Week Low | $0.04 | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $0.00 | |||
| Volume | 86,600 | |||||
| PROVECTUS BIOPHARMACEUTICALS, Inc. (AMEX: PVCT) | Delayed: 0.05 +0.01 (25.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $0.54 | |||
| Open | $0.05 | 52 Week Low | $0.04 | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $0.00 | |||
| Volume | 86,600 | |||||
